EGFR and skin squamous cell carcinoma: As such, the 2.4‐month median DOT and the 15.3‐month median OS reported in this study are highly consistent with previously reported results regarding the limited efficacy of cytotoxic chemotherapy and EGFR inhibitors in the treatment of advanced CSCC.